January 06, 2026 article Open access Universal vs. ASCO guidelines-based germline genetic testing for newly diagnosed breast cancer patients in resource-restricted settings Oncology Reviews DOI: 10.3389/or.2025.1638255 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 1 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 2022 Annals of Oncology article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent 473 citations The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review 2022 Cancers review Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 82 citations 2 results